Employees: 12 (2023.0)Legal category: 5785Size: PMECreation date: 2019-01-31 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NICE (06000), Alpes-Maritimes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE NICE RIVIERA is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NICE (06000),
this company of category PME
shows in 2024 a net income positive of 587 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE NICE RIVIERA (SIREN 847976396)
Indicator
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
586 953 €
370 019 €
657 764 €
1 126 327 €
331 740 €
-62 740 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELAS PHARMACIE NICE RIVIERA generates positive net income of 587 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
586 953 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 137%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 36%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
136.865%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
36.381%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Debt ratio
1083.116
582.001
185.339
118.866
114.366
136.865
Financial autonomy
7.058
12.753
30.027
42.135
41.666
36.381
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
136.872024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average+10 pts over 3 years
In 2024, the debt ratio of SELAS PHARMACIE NICE RIVIERA (136.87) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
36.38%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average-10 pts over 3 years
In 2024, the financial autonomy of SELAS PHARMACIE NICE RIVIERA (36.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 267.43. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
Liquidity ratio
182.506
322.632
360.479
657.229
403.746
267.43
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
267.432024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of SELAS PHARMACIE NICE RIVIERA (267.43) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of SELAS PHARMACIE NICE RIVIERA in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELAS PHARMACIE NICE RIVIERA is estimated at
8 194 297 €
(range 5 706 379€ - 12 259 138€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
5706k€8194k€12259k€
8 194 297 €Range: 5 706 379€ - 12 259 138€
NAF 5 année 2024
Valuation method used
Net Income Multiple
586 953 €
×
14.0x
=8 194 298 €
Range: 5 706 379€ - 12 259 138€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE NICE RIVIERA with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE NICE RIVIERA
What is the revenue of SELAS PHARMACIE NICE RIVIERA ?
The revenue of SELAS PHARMACIE NICE RIVIERA is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE NICE RIVIERA profitable?
Yes, SELAS PHARMACIE NICE RIVIERA generated a net profit of 587 k€ in 2024.
Where is the headquarters of SELAS PHARMACIE NICE RIVIERA ?
The headquarters of SELAS PHARMACIE NICE RIVIERA is located in NICE (06000), in the department Alpes-Maritimes.
Where to find the tax return of SELAS PHARMACIE NICE RIVIERA ?
The tax return of SELAS PHARMACIE NICE RIVIERA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE NICE RIVIERA operate?
SELAS PHARMACIE NICE RIVIERA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart